Squarepoint Ops LLC reduced its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 95.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,900 shares of the company's stock after selling 443,842 shares during the quarter. Squarepoint Ops LLC's holdings in Perrigo were worth $217,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Allworth Financial LP increased its stake in shares of Perrigo by 489.1% in the second quarter. Allworth Financial LP now owns 9,390 shares of the company's stock valued at $98,000 after purchasing an additional 7,796 shares during the period. Parrish Capital LLC boosted its position in shares of Perrigo by 4.3% during the second quarter. Parrish Capital LLC now owns 33,896 shares of the company's stock worth $352,000 after buying an additional 1,384 shares during the period. Corient Private Wealth LP boosted its position in shares of Perrigo by 215.7% during the second quarter. Corient Private Wealth LP now owns 40,854 shares of the company's stock worth $424,000 after buying an additional 27,914 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Perrigo in the 2nd quarter worth approximately $221,000. Finally, HB Wealth Management LLC acquired a new stake in Perrigo in the 2nd quarter valued at approximately $211,000. 95.91% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
PRGO has been the topic of several recent analyst reports. Wall Street Zen raised Perrigo from a "buy" rating to a "strong-buy" rating in a research note on Saturday, September 19th. Weiss Ratings raised Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $19.33.
View Our Latest Report on Perrigo
Perrigo Price Performance
Shares of NYSE PRGO opened at $14.72 on Friday. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $22.65. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of -1.18, a PEG ratio of 1.64 and a beta of 0.59. The firm has a 50-day moving average of $12.93 and a two-hundred day moving average of $11.49.
Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.11. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter in the previous year, the company posted ($0.06) EPS. The business's revenue was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts expect that Perrigo Company plc will post 2.18 earnings per share for the current fiscal year.
Perrigo Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a $0.29 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.16 annualized dividend and a dividend yield of 7.9%. Perrigo's dividend payout ratio is currently -9.27%.
Perrigo Company Profile
(
Free Report)
Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women's health.
The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.
Featured Stories
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.